 STONY BROOK, N.Y.--BUSINESS WIRE--Applied DNA Sciences, Inc. NASDAQ: APDN Applied DNA or the Company, today clarifies the scope of its newly authorized asymptomatic serial screening indication for its Linea COVID-19 Assay Kit the Assay Kit and certain information contained in its previously disseminated 12 May 2021 press release the Press Release relating to the U.S. Food and Drug Administrations FDA grant of a re-issued Emergency Use Authorization EUA that expands the Assa 